Practice Alert Podcast

ACP issues 4 statements on T2DM treatment targets

Author and Disclosure Information

In March 2018, The American College of Physicians issued 4 guidance statements on the use of hemoglobin A1c targets for nonpregnant adults with type 2 diabetes. In this audiocast, Dr. Doug Campos-Outcalt describes these statements and the ways that they differ—often significantly—from other guidelines.


 

Resource

Qaseem A, Wilt TJ, Kansagara D, et al, for the Clinical Guidelines Committee of the American College of Physicians. Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians. Ann Int Med. 2018; Mar 6. doi: 10.7326/M17-0939. [Epub ahead of print].

Recommended Reading

Use of HbA1c in the Diagnosis of Diabetes in Adolescents
Journal of Clinical Outcomes Management
Individualizing Treatment of Hyperglycemia in Type 2 Diabetes
Journal of Clinical Outcomes Management
Is Sitagliptin Plus Glargine Noninferior to Basal–Bolus Insulin for Inpatient Management of Type 2 Diabetes?
Journal of Clinical Outcomes Management
Prevention of Type 2 Diabetes: Evidence and Strategies
Journal of Clinical Outcomes Management
Patient-Physician Communication and Diabetes Self-Care
Journal of Clinical Outcomes Management
Cardiovascular Risk Reduction in Patients with Type 2 Diabetes
Journal of Clinical Outcomes Management
EMR-Based Tool for Identifying Type 2 Diabetic Patients at High Risk for Hypoglycemia
Journal of Clinical Outcomes Management
Approaches to Enhancing Patient-Centered Communication In Caring For Hispanic/Latino Patients With Diabetes
Journal of Clinical Outcomes Management
Medical associations fight American College of Physicians HBA1c recommendations
Journal of Clinical Outcomes Management
Guidelines May Help Reduce Stroke Risk in Patients With Diabetes
Journal of Clinical Outcomes Management